Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Aug 3, 2026
Reporting period
Not applicable
Filed with the SEC
Aug 5, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0002137804-26-000004
Filed / recorded
Aug 5, 2026, 3:59 AM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
Medtronic plc
Issuer CIK
1613103
Ticker
MDT
Reporting person
Kweli Thompson
Relationship
Officer
Officer title
EVP & President, Neuroscience
Security
Performance Share Units
Table
Derivative (Table II)
Transaction date
Aug 3, 2026
Transaction code
A
Shares / units
17,306
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
17,306
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 17,306 shares will be issued. If maximum performance metrics are achieved, 41,534 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
Around the same time
Congress tradeSits on House Ways and Means, Health
Congress tradeSits on House Ways and Means, Health
Congress trade